Humacyte Appoints Founder Laura Niklason MD, PhD as President and Chief Executive Officer

DURHAM, N.C.--(BUSINESS WIRE)--Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Laura Niklason MD, PhD has been appointed President and Chief Executive Officer. Jeffrey Lawson MD, PhD has been appointed the newly established role of Chief Surgical Officer and Vice Chairman. Dr. Laura Niklason, a world leader in tissue engineering and cellular therapies, founded Humacyte in 2004. Dr. Niklason has been deeply involved in all key aspects of Humacyte’s growth,

Click to view original post